Sep 28 2016 Publication Federalist Society Review A Second Look at the CREATES Act: What’s Not Being Said Erika Lietzan Federalist Society Review, Volume 17, Issue 3 Note from the Editor: This article critically discusses the CREATES Act, which is currently pending...
Sep 14 2017 Podcast FedSoc Forums Antitrust Implications of Pharmaceutical Pricing: from Martin Shkreli to EpiPen - Podcast Michael A. Carrier From Martin Shkreli to the Epipen, decisions about pharmaceutical pricing and distribution have been very...
A Second Look at the CREATES Act: What’s Not Being Said
Erika Lietzan
Federalist Society Review, Volume 17, Issue 3
Note from the Editor: This article critically discusses the CREATES Act, which is currently pending...
Antitrust Implications of Pharmaceutical Pricing: from Martin Shkreli to EpiPen - Podcast
Michael A. Carrier
From Martin Shkreli to the Epipen, decisions about pharmaceutical pricing and distribution have been very...